Stay updated on EAP Avapritinib in Advanced GIST Clinical Trial
Sign up to get notified when there's something new on the EAP Avapritinib in Advanced GIST Clinical Trial page.

Latest updates to the EAP Avapritinib in Advanced GIST Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page adds a Revision: v3.4.2 entry and removes older maintenance notices (including a funding status message and Revision: v3.4.1). These changes affect only site messaging and do not alter trial information.SummaryDifference0.6%

- Check23 days agoChange DetectedA government funding/status notice was added and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.7%

- Check30 days agoChange DetectedThe new page adds a Show glossary option and updates header/footer text, including Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, replacing the previous wording and version (v3.3.4).SummaryDifference0.3%

- Check44 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check66 days agoChange DetectedFooter now displays Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 references were removed.SummaryDifference0.2%

- Check94 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.2. This change does not affect the study content or its presentation.SummaryDifference0.1%

Stay in the know with updates to EAP Avapritinib in Advanced GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EAP Avapritinib in Advanced GIST Clinical Trial page.